CHECK THIS OUT Take a look at Phase.Biotech.com They wrote an article on ANX the other day that seems to be saying everything fox is saying now. I think ANX can be bought by GSK, SNY, or any other large pharma that needs a competitive drug (or to acquire their clear competition).